FindTrial
Sign In

Molecular mechanism of celecoxib on inflammatory cytokines and loss of apoptosis in respiratory papilloma

Molecular mechanism of celecoxib on inflammatory cytokines and loss of apoptosis in respiratory papilloma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021567
Enrollment
Unknown
Registered
2019-02-27
Start date
2019-02-25
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent respiratory papillomatosis

Interventions

papilloma cases:Celecoxib

Sponsors

Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 60 Years

Inclusion criteria

Inclusion criteria: A patient with recurrent respiratory papilloma.

Exclusion criteria

Exclusion criteria: 1. Patients prone to infection and fever; 2. Patients with autoimmune diseases; 3. Patients with malignant tumor diseases.

Design outcomes

Primary

MeasureTime frame
NF-KB;cox-2;bax;bcl-2;caspase-3;—

Countries

China

Contacts

Public ContactYang Xiao

Department of Otolaryngology, Head and Neck Surgery, Beijing Tongren Hospital

18910137727@163.com+86 18910137727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026